학술논문
72TiP AVALON trial: Phase IIb study of maveropepimut-s and low-dose cyclophosphamide in subjects with platinum-resistant, epithelial ovarian cancer
Document Type
Abstract
Author
Source
In ESMO Open February 2023 8(1) Supplement 1
Subject
Language
ISSN
2059-7029